Cargando…

TRPV2 is a novel biomarker and therapeutic target in triple negative breast cancer

Transient receptor potential vanilloid type-2 (TRPV2) is an ion channel that is triggered by agonists like cannabidiol (CBD). Triple negative breast cancer (TNBC) is an aggressive disease with limited therapeutic options. Chemotherapy is still the first line for the treatment of TNBC patients; howev...

Descripción completa

Detalles Bibliográficos
Autores principales:	Elbaz, Mohamad, Ahirwar, Dinesh, Xiaoli, Zhang, Zhou, Xinyu, Lustberg, Maryam, Nasser, Mohd W., Shilo, Konstantin, Ganju, Ramesh K.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2016
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6173360/ https://www.ncbi.nlm.nih.gov/pubmed/30323891 http://dx.doi.org/10.18632/oncotarget.9663

Ejemplares similares

Novel role of cannabinoid receptor 2 in inhibiting EGF/EGFR and IGF-I/IGF-IR pathways in breast cancer
por: Elbaz, Mohamad, et al.
Publicado: (2016)

C-X-C motif chemokine 12/C-X-C chemokine receptor type 7 signaling regulates breast cancer growth and metastasis by modulating the tumor microenvironment
por: Wani, Nissar Ahmad, et al.
Publicado: (2014)

Fatty acid binding protein 5 promotes metastatic potential of triple negative breast cancer cells through enhancing epidermal growth factor receptor stability
por: Powell, Catherine A., et al.
Publicado: (2015)

RAGE: A novel target for breast cancer growth and metastasis
por: Nasser, Mohd W., et al.
Publicado: (2016)

Macrophage migration inhibitory factor inhibition as a novel therapeutic approach against triple-negative breast cancer
por: Charan, Manish, et al.
Publicado: (2020)

Cannabidiol Inhibits Tumorigenesis in Cisplatin-Resistant Non-Small Cell Lung Cancer via TRPV2
por: Misri, Swati, et al.
Publicado: (2022)

Triple-negative breast cancer: promising prognostic biomarkers currently in development
por: Sukumar, Jasmine, et al.
Publicado: (2021)

FAAH inhibition enhances anandamide mediated anti-tumorigenic effects in non-small cell lung cancer by downregulating the EGF/EGFR pathway
por: Ravi, Janani, et al.
Publicado: (2014)

Fibroblast-Derived CXCL12 Promotes Breast Cancer Metastasis by Facilitating Tumor Cell Intravasation
por: Ahirwar, Dinesh K., et al.
Publicado: (2018)

Crosstalk between Chemokine Receptor CXCR4 and Cannabinoid Receptor CB(2) in Modulating Breast Cancer Growth and Invasion
por: Nasser, Mohd W., et al.
Publicado: (2011)

Sacituzumab govitecan: ascending the treatment algorithm in triple negative breast cancer
por: Rozenblit, Mariya, et al.
Publicado: (2022)

STAT1 gene deficient mice develop accelerated breast cancer growth and metastasis which is reduced by IL-17 blockade
por: Varikuti, Sanjay, et al.
Publicado: (2017)

Editorial: Inflammation and Myeloid Cells in Cancer Progression and Metastasis
por: Mishra, Sanjay, et al.
Publicado: (2022)

Augmentation of Extracellular ATP Synergizes With Chemotherapy in Triple Negative Breast Cancer
por: Manouchehri, Jasmine M., et al.
Publicado: (2022)

The Roles of Stroma-Derived Chemokine in Different Stages of Cancer Metastases
por: Hussain, Shahid, et al.
Publicado: (2020)

Racially Disparate Expression of mTOR/ERK-1/2 Allied Proteins in Cancer
por: Mishra, Sanjay, et al.
Publicado: (2021)

Molecular and Cellular Factors Associated with Racial Disparity in Breast Cancer
por: Charan, Manish, et al.
Publicado: (2020)

Non-contact method for directing electrotaxis
por: Ahirwar, Dinesh K., et al.
Publicado: (2015)

TRPV2: A Cancer Biomarker and Potential Therapeutic Target
por: Siveen, Kodappully S., et al.
Publicado: (2020)

Lipopolysaccharide from the commensal microbiota of the breast enhances cancer growth: role of S100A7 and TLR4
por: Wilkie, Tasha, et al.
Publicado: (2021)

Identification of DNA methylation biomarkers with potential to predict response to neoadjuvant chemotherapy in triple-negative breast cancer
por: Meyer, Braydon, et al.
Publicado: (2021)

Qualitative and Quantitative Image-Based Biomarkers of Therapeutic Response in Triple-Negative Breast Cancer
por: Golden, Daniel I., et al.
Publicado: (2018)

PKD1 is a potential biomarker and therapeutic target in triple-negative breast cancer
por: Spasojevic, Caroline, et al.
Publicado: (2018)

miR-29b defines the pro-/anti-proliferative effects of S100A7 in breast cancer
por: Zhao, Helong, et al.
Publicado: (2015)

Erratum to: miR-29b defines the pro-/anti-proliferative effects of S100A7 in breast cancer
por: Zhao, Helong, et al.
Publicado: (2015)

TTK is a favorable prognostic biomarker for triple-negative breast cancer survival
por: Xu, Qianqian, et al.
Publicado: (2016)

Immune-related biomarkers in triple-negative breast cancer
por: Zhang, Juan, et al.
Publicado: (2021)

Overview on Epigenetic Re-programming: A Potential Therapeutic Intervention in Triple Negative Breast Cancers
por: Hanif, Ezanee Azlina Mohamad, et al.
Publicado: (2018)

Therapeutic Potential of Albumin Nanoparticles Encapsulated Visnagin in MDA-MB-468 Triple-Negative Breast Cancer Cells
por: Alsrhani, Abdullah, et al.
Publicado: (2023)

Triple-Negative Breast Cancer: Adjuvant Therapeutic Options
por: Gucalp, Ayca, et al.
Publicado: (2011)

Therapeutic landscape in mutational triple negative breast cancer
por: Shi, Yaqin, et al.
Publicado: (2018)

Targeted Therapeutic Strategies for Triple-Negative Breast Cancer
por: Li, Ying, et al.
Publicado: (2021)

LncRNAs as new biomarkers to differentiate triple negative breast cancer from non-triple negative breast cancer
por: Lv, Mingming, et al.
Publicado: (2016)

Circular RNA: A potential diagnostic, prognostic, and therapeutic biomarker for human triple-negative breast cancer
por: Tian, Tian, et al.
Publicado: (2021)

Nodular pulmonary deposition disease in a patient with the acquired immunodeficiency syndrome: a case report
por: Mezzanotte, Jessica N., et al.
Publicado: (2020)

Therapeutic Strategies for Metastatic Triple-Negative Breast Cancers: From Negative to Positive
por: Nandini, Dey, et al.
Publicado: (2021)

Slit2-Mediated Metabolic Reprogramming in Bone Marrow-Derived Macrophages Enhances Antitumor Immunity
por: Kaul, Kirti, et al.
Publicado: (2021)

Endocan as a prognostic biomarker of triple-negative breast cancer
por: Sagara, Atsunobu, et al.
Publicado: (2016)

Exploring specific prognostic biomarkers in triple-negative breast cancer
por: Bao, Chang, et al.
Publicado: (2019)

Can MRI Biomarkers Predict Triple-Negative Breast Cancer?
por: Moffa, Giuliana, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_83a935doiksl42hdurbbnrom6k